Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

This study has been withdrawn prior to enrollment.
(Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the medication for the study.)
Sponsor:
Information provided by:
The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT00329316
First received: May 23, 2006
Last updated: June 26, 2008
Last verified: June 2007
  Purpose

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.


Condition Intervention
Pregnancy
Premature Birth
Drug: Crinone Gel 8%

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by The Baruch Padeh Medical Center, Poriya:

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies

-

Exclusion Criteria:

  • No medications for PTL or any kind of progesterone.
  • Cervical suture
  • Multiple pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00329316

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Study Chair: Yuri Perlitz, MD The Baruch Padeh Medical Center, Poriya
Principal Investigator: Mosheh Ben Ami, Prof. Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00329316     History of Changes
Other Study ID Numbers: PTL Progesterone Perlitz.CTIL
Study First Received: May 23, 2006
Last Updated: June 26, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by The Baruch Padeh Medical Center, Poriya:
Pre-term labor
progesterone

Additional relevant MeSH terms:
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Progesterone
Progestins
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on October 19, 2014